Strong Heart and Vascular Center
Cardiology
Our Providers
Christopher J. Cove, M.D.
Christopher J. Cove, M.D., is Assistant Professor of Medicine and Assistant Director of the Cardiac Catheterization Laboratories. He recently joined the faculty in October of 1998 after five years on staff as an interventional cardiologist at the Cleveland Clinic Foundation. He did his residency and cardiology fellowship training at the University of Rochester. Dr. Cove’s main clinical activities take place in the cardiac catheterization laboratories where he performs diagnostic and interventional procedures. His clinical interests include complex coronary interventions, primary angioplasty for acute infarcts and the use of gylcoprotein IIb/ IIIa platelet inhibitors for acute coronary syndromes.
Dr. Cove, along with his colleges in the interventional laboratories, is involved in several major clinical trials including the BETA-CATH, SMART, AVID and HALT-MI studies. His particular research interests include the use of percutaneous closure devices and the development of capture mechanisms and covered grafts for interventions performed in degenerated vein grafts.
Education / Certification
M.D., Cornell University School of Medicine – 1985
Chief Resident, Strong Memorial Hospital – 1988-89
Instructor and Fellow, University of Rochester Medicine and Dentistry – 1989-92
Research and Professional Experience
Ohio Permanente Medical Group, Interventional Cardiologist – 1993-1998
University of Rochester School of
Medicine and Dentistry, Associate Professor of Medicine/Cardiology – 1998-Present
University of Rochester School of Medicine and Dentistry, Assistant Director Cardiology Catheterization Laboratory – 1998-Present
References
- Cove CJ, Widman SC, Liang C, Schenk EA, Hood, Jr WB. Dobutamine effects on systole and diastole in rats with chronic myocardial infarction. Amer J Med Sci. 1995;309:5-12.
- Stuver TP, Cove CJ, Hood, Jr. WB. Mechanical abnormalities in the rat ischemic heart failure model which lie downstream to c AMP production. J Mol Cell Cardiol. 1994;26:1221-1226.
- Simpfendorfer C, Kottlke-Merchant K, Lowrie M, Anders RJ, Burns DM, Miller DP, Cove CJ, Defranco AC, Ellis SG, Moliterno DJ, Raymond RF, Sutton JM, Topol EJ. First chronic gylcoprotein IIb/IIIa integrin blockade. A randomized placebo-controlled pilot study of Xemilofiban in unstable angina with percutaneous coronary interventions. Circulation. 1997;96:76-81.
- Eisenberg MJ, Taylor JM, Cove CJ, Brown KJ, Ellis SG, Topol EJ. Comparison of percutaneous coronary revascularization costs among HMO and non-HMO cardiologists practicing at the same institution. J Cardiovasc Diag Proc 16; 109-119: 1999.
- Patel T, Cutlip DE, Cove CJ, Pomerantz RM, Ling FS. Intravascular ultrasound analysis of the effect of post-dilatation with non-compliant balloons following initial high pressure stent deployment using newer generation stent delivery systems. J AmerColl Card 35; 45A: 2000.
- Cutlip DE, Cove CJ, Irons D, Kalaria V, Le M, Cronmiller H, Caufield L, Pomerantz RM, Ling FS. Emergency room administration of eptifibatide before primary angioplasty for ST elevation acute myocardial infarction and its effect on baseline coronary flow and procedure outcomes. Am J Cardiol 88(1):A6,62-4, 2001.
- Kalaria VG, Chaudhary IC, Jacobson S, Cove CJ, Pomerantz R, Ling FS, Cutlip D. Evolution in the practice of primary angioplasty- Effect of adjunctive coronary stenting and glycoprotein IIb/IIIa inhibitors on long-term outcomes. Cathet Cardiovasc Intervent 2001;54:327-332.
Contact:
Dr. Christopher Cove
Paul N. Yu Heart Center
Strong Memorial Hospital
601 Elmwood Ave
Ambulatory Center - Ground Floor
Rochester, NY 14642
Phone: 585-275-2475